Evidence map›Paper›PMID 34922539›Full record

ArticleMolecular cancer2021

circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.

Cheng-Peng Gui, Bing Liao, Cheng-Gong Luo, Yu-Hang Chen, Lei Tan, Yi-Ming Tang, Jia-Ying Li, Yi Hou, Hong-De Song, Hai-Shan Lin and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tumor metabolic crosstalk and immunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Cheng-Peng Gui *Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Bing Liao *Department of Pathology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Cheng-Gong Luo *Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Yu-Hang Chen *Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Lei Tan *Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Yi-Ming TangDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Jia-Ying LiDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Yi HouDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Hong-De SongDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Hai-Shan LinDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Quan-Hui XuDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Gao-Sheng YaoDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Hao-Hua YaoDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Xi-LiuDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China.
Jun-Hang LuoDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China. luojunh@mail.sysu.edu.cn.
Jia-Zheng CaoDepartment of Urology, Affiliated Jiangmen Hospital, Sun Yat-sen University, Jiangmen, 529000, Guangdong, China.
Jin-Huan WeiDepartment of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China. weijh23@mail.sysu.edu.cn.
Sun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC.

methodscircCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization.

resultsThe expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression.

conclusionsWe found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC.

Indexed as

Biomarkers, TumorRNA, CircularAdaptor Proteins, Signal TransducingAdultAgedAnimalsCarcinoma, Renal CellCell Cycle ProteinsCell Line, TumorDisease Models, AnimalFemaleGene Expression Regulation, NeoplasticHeterograftsHumansKidney NeoplasmsMaleAdaptor Proteins, Signal TransducingBiomarkers, TumorCell Cycle ProteinsCHST15 protein, humanEIF4EBP1 protein, humanMembrane GlycoproteinsMicroRNAsMIRN125 microRNA, humanRNA, CircularSulfotransferasesClear cell renal cell carcinomaEIF4EBP1hsa_circ_0020303MetastasismiR-125a-5pProliferation

Identifiers

PMID34922539
PMCPMC8684108
OpenAlexW4200455418

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.